You are reading one round. Fundz also knows which of your own LinkedIn connections can open this account.See it live →
TuHURA Biosciences Secures $650,000 Loan to Support Operations
PRIVATESep 14, 2026•4 days ago
Amount Raised
$650,000
Round Type
Debt Financing
TampaBiotechnologyHealth CareTherapeutics
Investors
Parkview Holdings One Llc
Description
On September 14, 2026, TuHURA Biosciences, Inc. borrowed an additional $650,000 under a revolving credit facility with Parkview Holdings One LLC. The company plans to utilize these funds for general corporate purposes. This funding bolsters TuHURA's financial resources as it continues its developmental initiatives.
Company Information
Company
TuHURA Biosciences
Location
10500 University Center Drive
Tampa, Florida, United States
About
Morphogenesis, Inc. Announces Corporate Rebranding to TuHURA Biosciences, Inc. TuHURA Biosciences, Inc. is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The Company’s technologies are designed to overcome primary and acquired resistance to checkpoint inhibitors or cellular therapies in the treatment of cancer.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment TuHURA Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.